Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study
In this prospective cohort study, Jon Hazeldine and colleagues investigate the immune and inflammatory response of trauma patients immediately after and in the hours and days following injury.
Vyšlo v časopise:
Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study. PLoS Med 14(7): e32767. doi:10.1371/journal.pmed.1002338
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002338
Souhrn
In this prospective cohort study, Jon Hazeldine and colleagues investigate the immune and inflammatory response of trauma patients immediately after and in the hours and days following injury.
Zdroje
1. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury. 2003; 34:397–404. 12767787
2. Hazeldine J, Hampson P, Lord JM. The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review. Burns and Trauma. 2016. doi: 10.1186/s41038-016-0059-3 27672669
3. Hampson P, Dinsdale RJ, Wearn CM, Bamford AL, Bishop JR, Hazeldine J, et al. Neutrophil Dysfunction, Immature Granulocytes, and Cell-free DNA are Early Biomarkers of Sepsis in Burn-injured Patients: A Prospective Observational Cohort Study. Ann.Surg. 2016. doi: 10.1097/SLA.0000000000001807 27232244
4. Liao Y, Liu P, Guo F, Zhang ZY, Zhang Z. Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS ONE. 2013. 8: e68963. doi: 10.1371/journal.pone.0068963 23894384
5. Li H, Itagaki K, Sandler N, Gallo D, Galenkamp A, Kaczmarek E, et al. Mitochondrial damage-associated molecular patterns from fractures suppress pulmonary immune responses via formyl peptide receptors 1 and 2. J.Trauma Acute.Care Surg. 2015;78: 272–279. doi: 10.1097/TA.0000000000000509 25757111
6. Marks W, Dropiewska G, Bryl E, Dudek R, Wieruszewski J, Stasiak M, et al. Immunomonitoring in patients with early moderate and severe head trauma. Cent. Eur. J. Public Health. 2013;38: 494–499.
7. Perez-Barcena J, Regueiro V, Crespi C, Pierola J, Oliver A, Llompart-Pou JA, et al. Expression of toll-like receptors 2 and 4 is upregulated during hospital admission in traumatic patients: lack of correlation with blunted innate immune responses. Ann.Surg. 2010;251: 521–527. doi: 10.1097/SLA.0b013e3181cc8f84 20134316
8. Laudanski K, Miller-Graziano C, Xiao W, Mindrinos MN, Richards DR, De A, et al. Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc.Natl.Acad.Sci.U.S.A 2006;103: 15564–15569. doi: 10.1073/pnas.0607028103 17032758
9. Manson J, Cole E, De'Ath HD, Vulliamy P, Meier U, Pennington D, et al. Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients. Crit Care 2016;20: 176. doi: 10.1186/s13054-016-1341-2 27268230
10. Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van LA, et al. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016;42: 551–561. doi: 10.1007/s00134-015-4205-3 26912315
11. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch.Surg. 2000;135: 291–295. 10722030
12. Arand M, Melzner H, Kinzl L, Bruckner UB, Gebhard F. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbecks Arch.Surg. 2001;386: 241–248. 11466564
13. Hietbrink F, Koenderman L, Althuizen M, Pillay J, Kamp V, Leenen LP. Kinetics of the innate immune response after trauma: implications for the development of late onset sepsis. Shock 2013;40: 21–27. doi: 10.1097/SHK.0b013e318295a40a 23603769
14. Visser T, Hietbrink F, Groeneveld KM, Koenderman L, Leenen LP. Isolated blunt chest injury leads to transient activation of circulating neutrophils. Eur.J.Trauma Emerg.Surg. 2011;37: 177–184. doi: 10.1007/s00068-010-0041-x 21837259
15. West SD, Goldberg D, Ziegler A, Krencicki M, Du Clos TW, Mold C. Transforming growth factor-beta, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients. PLoS ONE. 2012;7: e52406. doi: 10.1371/journal.pone.0052406 23285029
16. Wolach B, Sazbon L, Gavrieli R, Broda A, Schlesinger M. Early immunological defects in comatose patients after acute brain injury. J.Neurosurg. 2001;94: 706–711. doi: 10.3171/jns.2001.94.5.0706 11354400
17. Kasten KR, Goetzman HS, Reid MR, Rasper AM, Adediran SG, Robinson CT, et al. Divergent adaptive and innate immunological responses are observed in humans following blunt trauma. BMC.Immunol. 2010;11: 4. doi: 10.1186/1471-2172-11-4 20100328
18. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J.Exp.Med. 2011;208: 2581–2590. doi: 10.1084/jem.20111354 22110166
19. Vanzant EL, Hilton RE, Lopez CM, Zhang J, Ungaro RF, Gentile LF, et al. Advanced age is associated with worsened outcomes and a unique genomic response in severely injured patients with hemorrhagic shock. Crit Care 2015. 19: 77. doi: 10.1186/s13054-015-0788-x 25880307
20. Orr SK, Butler KL, Hayden D, Tompkins RG, Serhan CN, Irimia D. Gene Expression of Proresolving Lipid Mediator Pathways Is Associated With Clinical Outcomes in Trauma Patients. Crit Care Med. 2015;43: 2642–2650. doi: 10.1097/CCM.0000000000001312 26488221
21. Namas RA, Vodovotz Y, Almahmoud K, Abdul-Malak O, Zaaqoq A, Namas R, et al. Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans. Ann.Surg. 2016; 263: 191–198. doi: 10.1097/SLA.0000000000001001 25371118
22. Jeschke MG, Gauglitz GG, Finnerty CC, Kraft R, Mlcak RP, Herndon DN. Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories. Ann.Surg. 2014;259: 814–823. doi: 10.1097/SLA.0b013e31828dfbf1 23579577
23. Kraft R, Herndon DN, Finnerty CC, Cox RA, Song J, Jeschke MG. Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study. Shock 2015;43: 222–227. doi: 10.1097/SHK.0000000000000294 25514427
24. Cuschieri J, Bulger E, Schaeffer V, Sakr S, Nathens AB, Hennessy L, et al. Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure. Shock 2010;34: 346–351. doi: 10.1097/SHK.0b013e3181d8e687 20844410
25. Ferreira LC, Regner A, Miotto KD, Moura S, Ikuta N, Vargas AE, et al. Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj. 2014;28: 1311–1316. doi: 10.3109/02699052.2014.916818 24830571
26. Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, Neugebauer EA, et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007;28: 668–674. 18092384
27. Muszynski JA, Nofziger R, Greathouse K, Nateri J, Hanson-Huber L, Steele L, et al. Innate immune function predicts the development of nosocomial infection in critically injured children. Shock 2014;42: 313–321. doi: 10.1097/SHK.0000000000000217 24978895
28. Gouel-Cheron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS ONE 2012;7: e33095. doi: 10.1371/journal.pone.0033095 22431998
29. Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C, et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 2010;14: R208. doi: 10.1186/cc9331 21092108
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 1995. 57: 289–300.
31. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21: 128–138. doi: 10.1097/EDE.0b013e3181c30fb2 20010215
32. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J.Clin.Epidemiol. 2001;54: 774–781. 11470385
33. Liu CL, Tangsombatvisit S, Rosenberg JM, Mandelbaum G, Gillespie EC, Gozani OP, et al. Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Arthritis Res.Ther. 2012;14: R25. doi: 10.1186/ar3707 22300536
34. Pillay J, Kamp VM, van HE, Visser T, Tak T, Lammers JW, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J.Clin.Invest 2012; 122: 327–336. doi: 10.1172/JCI57990 22156198
35. Laborde RR, Lin Y, Gustafson MP, Bulur PA, Dietz AB. Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses. Front Immunol. 2014;5: 147. doi: 10.3389/fimmu.2014.00147 24772111
36. Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study. Crit Care 2009; 13: R88. doi: 10.1186/cc7914 19519886
37. Rainer TH, Ng MH, Lam NY, Chan TY, Cocks RA. Role of monocyte L-selectin in the development of post-traumatic organ failure. Resuscitation 2001;51: 139–149. 11718969
38. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J.Trauma Acute.Care Surg. 2012;72: 1491–1501. doi: 10.1097/TA.0b013e318256e000 22695412
39. Nakagawa M, Terashima T, D'yachkova Y, Bondy GP, Hogg JC, van Eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 1998;98: 2307–2313. 9826319
40. Drifte G, Dunn-Siegrist I, Tissieres P, Pugin J. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit Care Med. 2013;41: 820–832. doi: 10.1097/CCM.0b013e318274647d 23348516
41. Pillay J, Ramakers BP, Kamp VM, Loi AL, Lam SW, Hietbrink F, et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J.Leukoc.Biol. 2010;88: 211–220. doi: 10.1189/jlb.1209793 20400675
42. Sauce D, Dong Y, Campillo-Gimenez L, Casulli S, Bayard C, Autran B, et al. Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62Ldim Immunosuppressive Subset. J.Gerontol.A Biol.Sci.Med.Sci. 2017;72: 163–172. doi: 10.1093/gerona/glw062 27069096
43. Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011;117: 872–881. doi: 10.1182/blood-2010-05-283820 21063024
44. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, et al. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 2010;70: 443–455. doi: 10.1002/pros.21078 19902470
45. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008;135: 234–243. doi: 10.1053/j.gastro.2008.03.020 18485901
46. Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009;50: 799–807. doi: 10.1002/hep.23054 19551844
47. Xiu B, Lin Y, Grote DM, Ziesmer SC, Gustafson MP, Maas ML, et al. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma. Blood Cancer J. 2015; 5: e328. doi: 10.1038/bcj.2015.56 26230952
48. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J.Immunol. 2006;177: 7184–7192. 17082636
49. Rosenthal J, Thurman GW, Cusack N, Peterson VM, Malech HL, Ambruso DR. Neutrophils from patients after burn injury express a deficiency of the oxidase components p47-phox and p67-phox. Blood 1996;88: 4321–4329. 8943869
50. Junger WG, Rhind SG, Rizoli SB, Cuschieri J, Baker AJ, Shek PN, et al. Prehospital hypertonic saline resuscitation attenuates the activation and promotes apoptosis of neutrophils in patients with severe traumatic brain injury. Shock 2013;40: 366–374. doi: 10.1097/SHK.0000000000000038 24088993
51. Benna JE, Dang PM, Gaudry M, Fay M, Morel F, Hakim J, et al. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J.Biol.Chem. 1997; 272: 17204–17208. 9202043
52. Nauseef WM, Volpp BD, McCormick S, Leidal KG, Clark RA. Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J.Biol.Chem. 1991;266: 5911–5917. 1848559
53. Raad H, Paclet MH, Boussetta T, Kroviarski Y, Morel F, Quinn MT, et al. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox. FASEB J. 2009;23: 1011–1022. doi: 10.1096/fj.08-114553 19028840
54. Tarlowe MH, Kannan KB, Itagaki K, Adams JM, Livingston DH, Hauser CJ. Inflammatory chemoreceptor cross-talk suppresses leukotriene B4 receptor 1-mediated neutrophil calcium mobilization and chemotaxis after trauma. J.Immunol. 2003;171: 2066–2073. 12902512
55. Hirose T, Hamaguchi S, Matsumoto N, Irisawa T, Seki M, Tasaki O, et al. Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients. PLoS ONE. 2014;9: e111755. doi: 10.1371/journal.pone.0111755 25392950
56. Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, et al. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology 2015;62: 600–614. doi: 10.1002/hep.27841 25855125
57. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 2009;13: R174. doi: 10.1186/cc8152 19887013
58. Torrance HD, Vivian ME, Brohi K, Prowle JR, Pearse RM, Owen HC, et al. Changes in gene expression following trauma are related to the age of transfused packed red blood cells. J.Trauma Acute.Care Surg. 2015;78: 535–542. doi: 10.1097/TA.0000000000000534 25710424
59. Torrance HD, Brohi K, Pearse RM, Mein CA, Wozniak E, Prowle JR, et al. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann.Surg. 2015; 261: 751–759. doi: 10.1097/SLA.0000000000000653 24670848
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study
- Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines
- Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
- Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models